ERBB2 and gastric cancer: In contrast, the functional link between FASN and HER2 in HER2+ GC remains to be elucidated, even though it was reported that GC patients with concordant expression of FASN and HER2 are more likely to suffer a poor prognosis than patients with non concordant expression [23].